Background Fetal cells can be found in the maternal circulation in mos
t pregnancies. Fetal progenitor cells have been found to persist in th
e circulation of women many years after childbirth. We tested the hypo
thesis that microchimerism is involved in the pathogenesis of sclerode
rma. Scleroderma is of interest because of a strong female predilectio
n, an increased incidence in the years after childbearing, and clinica
l similarities between scleroderma and chronic graft-versus-host disea
se after allogeneic bone-marrow transplantation. We also investigated
whether HLA-compatibility of a child was associated with later develop
ment of scleroderma in the mother. Methods We enrolled 40 women who ha
d previously given birth to at least one son-16 healthy controls, 17 s
cleroderma and seven healthy sisters of quantitative PCR to Y-chromoso
me-specific sequence in blood from these women. Also 32 children, and
21 scleroderma patients with 47 children were HLA genotyped. Findings
The mean number of male cell DNA equivalents among controls was 0.38 c
ells per 16 mL whole blood (median 0 [range 0-2]) and 11.1 (6.0 [0-61]
) among scleroderma patients (p=0.0007). Controls' youngest sons were
born a mean of 15.4 years previously, and scleroderma patients' sons 1
8.5 years previously. Some scleroderma patients had concentrations of
male DNA higher than those found in most pregnant women, HLA-class II
compatibility of a child from the mother's perspective was more common
among scleroderma patients than among controls, but was not essential
for persistence of male DNA in maternal peripheral blood. Interpretat
ion Low concentrations of male DNA can be detected in healthy women de
cades after the birth of a son. Microchimerism in scleroderma patients
could be secondary to the underlying disease. However, the finding th
at HLA class II compatibility of a child was more common for scleroder
ma patients than for controls, supports the possibility that microchim
erism may be involved in the pathogenesis of scleroderma.